Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation.
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsCell-autonomous correction of ring chromosomes in human induced pluripotent stem cellsFluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogrammingThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsStem cells and bone diseases: new tools, new perspectiveThe Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone DisordersPluripotent Stem Cells and Skeletal Regeneration--Promise and Potential.Stem and progenitor cells: advancing bone tissue engineering.Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signalingBMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence.iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review.Osteogenic Differentiation in Healthy and Pathological Conditions.Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva.Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction.Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder.Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.A Unique ISR Program Determines Cellular Responses to Chronic Stress.Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cellsAn mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans ProgressivaMesenchymal Stem Cell Therapy for Bone Regeneration
P2860
Q54832071-FBF3E94C-1E34-40A4-82BC-67D2A4303360Q54832074-1C54D9F8-A95B-433A-A42F-8D66E9F38136Q54832075-C5091BE7-C512-4C1B-905E-A9ABA8415226Q54832076-308B5916-0D9E-4804-9BD0-F76F78045C9BQ54832077-A263F5E5-2F0F-4009-9B03-A5E5432689EDQ54832078-A3B4557B-ACC5-431B-9445-731FCA069E2AQ54833009-1C9BD7BD-FA55-4F98-8260-535E69DE5FB7Q54833010-BABA480C-7F32-4EAF-92DC-3E9EF0B5CC44Q54833011-4E085695-B1B3-4D05-8007-BD876C054CE0Q54833012-FFCE5A64-2F92-4320-9BDF-129E77489937Q54993071-5C6F5C2B-F82E-4C7F-B14C-612025D4352FQ54993073-597F3917-2AB0-49F3-82C0-DAD0E01D7C13Q54993075-4F5053EB-2778-43ED-BD19-479306AC70B6Q54993077-CF3D055A-8E84-45CE-A55E-7F1E17A6D6B4Q54993078-23444CB3-FFC8-4D61-BADE-40922E66C7C4Q54993080-24F1BF96-27DF-4F32-968C-E8ABFCC99E26Q54993082-3798F0FF-AEB4-4143-B356-B572C833531AQ54993436-4D1B07C5-9FDF-43FF-8F19-92EB471053B9Q54993437-5E122247-BBAD-4FC1-BAB3-3402E8136C8E
P1343
Q26751506-DE1445DF-142D-45F3-86D2-FF3EC3FC670FQ26775122-6B7C89B1-B8DE-4BA2-8FF7-67098F4F1ED5Q33648633-FEE7FC5C-EE8F-4987-B9D4-6DA272BC4100Q33767976-DB81C525-98E9-46C6-9739-FEDF6A8EFC40Q33851544-5471551F-E4DC-4F08-9157-1A0850CE78A4Q33925049-DC6834A8-D49E-4B0B-9538-C33F01E99C5DQ34990691-523C5D6C-343C-4DB2-97E5-14680E6887C0Q36029693-533EF456-C720-415A-A293-A221F2126B7AQ36303725-9EFEAAE8-C65C-463D-8180-F9EEE616FB53Q36394399-1E4822CD-30CD-40B8-8EC5-594641885961Q37057699-D7A16E60-1796-4F2B-9394-873C586876E1Q37182424-7E7753BC-0D5C-4A4B-9B6B-8273AB04827EQ37469332-6E1D8E48-C3E0-4946-B628-3449CB01199AQ38733804-EC86746C-D293-41C9-BCE1-6200ABE25B31Q39062996-A3CB8044-3EB2-4B65-B1A9-0B35714DA241Q39439904-CAF4D05F-D58A-4833-9F35-5C921AA5EE6BQ41215881-0B33C745-36D2-45DF-8F95-AAD150F55E3FQ42057000-9C29BD22-99F9-4493-84F9-618BC561A5A3Q44315676-FB840F2B-749A-46D0-8A00-414711691ABAQ46976609-C3DC8D29-9998-4911-A152-B178F1D83837Q47114501-197E13AB-C122-4A97-B9E9-D10547398664Q47315154-7573D140-5644-4566-A334-9385EC1861BEQ48009686-2C1D0CCE-B12C-4C2F-92E3-6C8001B8DC89Q55187124-3EB348D6-7773-41AE-A927-369049DD394BQ57167748-93F449BC-F9F9-4C82-8843-0F7C3A04469FQ58569719-B804C097-7FFD-4E9D-A607-CFDD92118E40Q58720492-DDEAC0F9-6735-4D82-A725-4082068E3139
P2860
Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induced pluripotent stem cells ...... ation and cartilage formation.
@en
Induced pluripotent stem cells ...... ation and cartilage formation.
@nl
type
label
Induced pluripotent stem cells ...... ation and cartilage formation.
@en
Induced pluripotent stem cells ...... ation and cartilage formation.
@nl
prefLabel
Induced pluripotent stem cells ...... ation and cartilage formation.
@en
Induced pluripotent stem cells ...... ation and cartilage formation.
@nl
P2093
P2860
P4510
P50
P921
P356
P1476
Induced pluripotent stem cells ...... ation and cartilage formation.
@en
P2093
Akira Nasu
Bruce R Conklin
Edward C Hsiao
Emilie Barruet
Hannah Kim
Isao Asaka
Junya Toguchida
Salma Sami
Shiro Baba
Takanobu Otsuka
P2860
P2888
P356
10.1186/1750-1172-8-190
P577
2013-12-09T00:00:00Z
P5875
P6179
1018625020